365
Views
25
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

An Evaluation of Patients' Willingness to Trade Symptom-Free Days for Asthma-Related Treatment Risks: A Discrete Choice Experiment

, , , , , , & show all
Pages 630-638 | Published online: 02 Jul 2009

References

  • Statistics Canada. National population health survey. 2001, Retrieved 20 June 2006; Available from http://www40.statcan.ca/l01/cst01/health50a.htm
  • Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma: National Heart, Blood, Lung Institute. Full Report 2007
  • World Health Organization. World Health Report 2003: Shaping the future, Retrieved 24 April 2006; Available from http://www.who.int/whr/2003/en/index.html
  • Global Initiative for Asthma. Pocket guide for asthma management and prevention. National Institute of Health, Bethesda (MD) Nov, 1998, NIH Pub. No. 96-3569B
  • Boulet L-P, Becker A, Bérubé D, Beveridge R, Ernst P. Canadian asthma consensus report. Can Med Assoc J 1999; 161(11 Supp)S1–62
  • The British Thoracic Society, the British Paediatric Association, the Royal College of Physicians of London, the King's Fund Centre, the National Asthma Campaign, the Royal College of General Practitioners, the General Practitioners in Asthma Group, the British Association of Accident and Emergency Medicine, and the British Paediatric Respiratory Group. Guidelines on the management of asthma. Thorax 1993; 48(Suppl 2)S1–24
  • Chapman K R, Ernst P, Grenville A, Dewland P, Zimmerman S. Control of asthma in Canada: failure to achieve guideline targets. Can Respir J 2001; 8(Suppl A)35A–40A
  • Anis A H, Lynd L D, Wang X H, King G, Spinelli J J, FitzGerald M, Bai T, Paré P. Double trouble: inappropriate asthma medication use linked to increased use of health care resources. Can Med Assoc J 2001; 164(5)625–31
  • Lynd L D, Guh D P, Paré P D, Anis A H. Patterns of inhaled asthma medication use: a 3-year longitudinal analysis of prescription claims data from British Columbia, Canada. Chest 2002; 122(6)1973–1981
  • FitzGerald J M, Boulet L-P, McIvor R A, Zimmerman S, Chapman K R. Asthma control in Canada remains sub optimal: the Reality of Asthma control (TRAC) study. Can Respir J 2006; 13: 253–259
  • Paltiel A D, Fuhlbrigge A L, Kitch B T, Liljas B, Weiss S T, Neumann P J, Kuntz K M. Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: results from the asthma policy model. J Allery Clin Immunol 201; 108(1)39–46
  • Lynd L D, Sandford A J, Kelly E A, Paré P D, Bai T R, FitzGerald J M, Anis A H. Reconcilable differences—a cross-sectional study of the relationship between socioeconomic status and the magnitude of short-acting-agonist use in asthma. Chest 2004; 126(4)1161–1168
  • Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000; 343(5)332–336
  • Little P, Everitt H, Williamson I, Warner G, Moore M, Gould C, Ferrier K, Payne S. Observational study of effect of patient centredness and positive approach on outcomes of general practice consultations. BMJ 2001; 323: 908–911
  • Streiner D L, Norman G R. Health measurement scales. A practical guide to their development and use. 2nd ed. Oxford University Press, New York 1989
  • Von Neuman J, Morgensterm O. Theory of games and economic behaviour. Wiley, New York 1953
  • Torrance G W, Thomas W H, Sackett D L. A utility maximization model for evaluation of health care programs. Health Serv Res 1972; 7: 119–133
  • Maas A, Stalpers L. Assessing utilities by means of conjoint measurement: an application in medical decision analysis. Med Decis Making 1992; 12(4)288–297
  • Ryan M, Bate A, Eastmond D J, Ludbrook A. Use of discrete choice experiments to elicit preferences. Qual Health Care 2001; 10(Suppl 1)i55–i60
  • Johnson F R, Desvousges W H, Ruby M C, Stieb D, De Civita P. Eliciting stated health preferences: an application to willingness to pay for longevity. Med Decision Making 1998; 18: S57–S67
  • Johnson F R, Banzhaf M R, Desvousges W H. Willingness to pay for improved respiratory and cardiovascular health: a multiple-format, stated preference approach. Health Econ 2000; 9: 295–317
  • Balsbaugh T A, Chambers C V, Diamond J J. Asthma controller medications: what do patients want?. J Asthma 1999; 36(7)591–596
  • Johansson G, Stallberg B, Tornling G, Andersson S, Karlsson G S, Fält K, Berggren F. Asthma treatment preference study: a conjoint analysis of preferred drug treatments. Chest 2004; 125: 916–923
  • Ratcliffe J, Van Haselen R, Buxton M, Hardy K, Coleman J, Partridge M. Assessing patients' preferences for characteristics associated with homeopathic and conventional treatment of asthma: a conjoint analysis study. Thorax 2002; 57: 503–508
  • Osman L M, McKenzie L, Cairns J, Friend J A, Godden D J, Legge J S, Douglas J G. Patient weighting of importance of asthma symptoms. Thorax 2001; 56: 138–142
  • Lancsar E J, Hall J P, King M, Kenny P, Louviere J J, Fiebig D G, Hossain I, Thien F C, Reddel H K, Jenkins C R. Using discrete choice experiments to investigate subject preferences for preventive asthma medication. Respirol 2007; 12: 127–136
  • King M, Hall J, Lanscar E, Fiebig D, Hossain I, Louviere J, Reddel H K, Jenkins C R. Patient preference for managing asthma: a discrete choice experiment. Health Econ 2007; 16(7)703–717
  • Kocur G, Adlter T, Hyman W, Aunet B. Guide to forecasting travel demand with direct utility assessment. United States Department of Transportation, Washington, DC 1982, Report No.: UMTA-NH-11-0001-82-1
  • Hensher D A, Rose J M, Greene W H. Applied choice analysis: A primer. Cambridge University Press, Cambridge 2005
  • Crapo R O, Morris A H, Gardner R M. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981; 123(6)659–664
  • American Thoracic Society. Standardization of spirometry–1987 update. Statement of the American Thoracic Society. Am Rev Respir Dis 1987; 136(5)1285–1298
  • Juniper E F, Guyatt G H, Ferrie P J, Griffith L E. Measuring quality of life in asthma. Am Rev Respir Dis 1993; 147(4)832–838
  • Juniper E, Guyatt G, Epstein R. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992; 47: 76–83
  • Juniper E F, Buist A S, Cox F M, Ferrie P J, King D R. Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest 1999; 115(5)1265–1270
  • McFadden D. Econometric models of probabilistic choice. Structural Analysis of Discrete Data with Economic Applications, C F Manski, D McFadden. MIT Press, Boston 1981; 422–434
  • SAS: The MDC procedure. 2006, Retrieved 2 April 2006; Available from http://support.sas.com/rnd/app/papers/mdc.pdf
  • Ryan M, Gerard K. Using discrete choice experiments to evaluate health care programmes: current practice and future reflections. Appl Health Econ Health Policy 2003; 2(1)55–64
  • Ryan M, Skåtun D. Modeling non-demanders in choice experiments. Health Econ 2004; 11: 397–402
  • Cheung S, Long J S. Testing for IIA in the multinomial logit model. Sociol Methods Res 2007; 35(4)583–600
  • Ryan M, Major K, Skatun D. Using discrete choice experiments to go beyond clinical outcomes when evaluating clinical practice. J Eval Clin Pract 2005; 11(4)328–338
  • Lanscar E, Louviere J. Deleting ‘irrational’ responses from discrete choice experiments: a case of investigation or imposing preferences?. Health Econ 2006; 15: 797–811
  • Blumenschein K, Johannesson M. Relationship between quality of life instruments, health state utilities, and willingness to pay in patients with asthma. Ann Allergy Asthma Immunol 1998; 80(2)189–194
  • Zillich A J, Blumenschein K, Johannesson M, Freeman P. Assessment of the relationship between measures of disease severity, quality of life, and willingness to pay in asthma. Pharmacoeconomics 2002; 20(4)257–265
  • Government of British Columbia, Ministry of Health: Pharmacare. 2006, Retrieved 8 August 2006; Available from http://www.healthservices.gov.bc.ca/pharme/plani/planiinfo.html#M
  • Mark T L, Swait J. Using stated preference and revealed preference modeling to evaluate prescribing decision. Health Econ 2004; 13: 563–573
  • Ratcliffe J, Buxton M, McGarry T, Sheldon R, Chancellor J. Patients' preferences for characteristics associated with treatments for arthritis. Rheumatol 2004; 43: 337–345
  • Sculpher M J, Buxton M J. The episode-free day as a composite measure of effectiveness. Pharmacoeconomics 1993; 4: 345–352

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.